Mold Contamination Leads to Hospira Lactated Ringer Recall

A recall has been issued for a caloric fluid and electrolyte replenishment supplement manufactured by Hospira, after mold contamination was discovered that could cause life-threatening injuries. 

A Hospira Lactated Ringer’s and 5% Dextrose Injection, USP, 1000 mL recall was announced October 5, after reports indicated that a leak between the cobra cap and fill-tube seal may be contaminated with mold.

The container of the fluid has an overwrap that may not be sterile, and when this fluid leaks, it may become trapped within the container and the overwrap, allowing for moisture to enter the pathway and cause mold to possibly be administered to the consumer.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The affected injection fluid was distributed throughout the U.S., except for Alaska, between January 2012 and June 2012. Recalled products have an NDC# and Batch# 0409-7929-0912-160-JT, which may also be followed by 01 or 09. The packaging contains an expiration date of December 1, 2013.

Mold ingestion can cause serious adverse consequences that may be life threatening. In many, case mold ingestion symptoms will surface within 12-24 hours after exposure, causing abdominal cramps, persistent diarrhea, dehydration, nausea, or an overall upset stomach.

Intravenously ingested mold could also potentially lead to septicemia, which can progress to septic shock causing a sometimes fatal blood stream infection.

Hospira has initiated an investigation that is still ongoing to determine the cause of defective product and solutions to prevent harm to their consumers. For medical inquiries consumers can contact 1-800-615-0187 or to report adverse events visit www.fda.gov/medwatch/report.htm.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges
Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges (Posted yesterday)

A Kentucky man's lawsuit claims Ozempic and Rybelsus side effects led to multiple trips to the emergency room due to nausea, vomiting and other reactions to his intestinal muscles being unable to push food through his digestive tract.

Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures
Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures (Posted yesterday)

Lawyers will be meeting with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, 2024, to finalize information needed to select a group of representative cases for bellwether discovery and trial.

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted 2 days ago)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.